These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30292687)

  • 1. The increased severity of acute pancreatitis in the elderly is mainly related to intestinal barrier dysfunction.
    Machado MCC; Souza HP
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):575-577. PubMed ID: 30292687
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of gut microbiota on intestinal barrier function in acute pancreatitis.
    Li XY; He C; Zhu Y; Lu NH
    World J Gastroenterol; 2020 May; 26(18):2187-2193. PubMed ID: 32476785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut barrier dysfunction in patients with acute pancreatitis.
    Ammori BJ
    J Hepatobiliary Pancreat Surg; 2002; 9(4):411-2. PubMed ID: 12483261
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of intestinal mucosa oxidative stress in gut barrier dysfunction of severe acute pancreatitis.
    Tian R; Tan JT; Wang RL; Xie H; Qian YB; Yu KL
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):349-55. PubMed ID: 23426538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats.
    Andersson R; Wang X; Sun Z; Deng X; Soltesz V; Ihse I
    Pancreas; 1998 Aug; 17(2):107-19. PubMed ID: 9700940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early gut barrier dysfunction in patients with severe acute pancreatitis: attenuated by continuous blood purification treatment.
    Zhang J; Yuan C; Hua G; Tong R; Luo X; Ying Z
    Int J Artif Organs; 2010 Oct; 33(10):706-15. PubMed ID: 21077043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early gut mucosal dysfunction in patients with acute pancreatitis.
    Liu H; Li W; Wang X; Li J; Yu W
    Pancreas; 2008 Mar; 36(2):192-6. PubMed ID: 18376312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagonlike peptide 2 protects intestinal barrier in severe acute pancreatitis through regulating intestinal epithelial cell proliferation and apoptosis.
    Chen X; Zhao HX; Fu XS; Li CP; Zhong XL
    Pancreas; 2012 Oct; 41(7):1080-5. PubMed ID: 22481288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of intestinal mucosal permeability function in patients with acute pancreatitis.
    Nagpal K; Minocha VR; Agrawal V; Kapur S
    Am J Surg; 2006 Jul; 192(1):24-8. PubMed ID: 16769270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
    Leveau P; Wang X; Sun Z; Börjesson A; Andersson E; Andersson R
    Biochem Pharmacol; 2005 May; 69(9):1325-31. PubMed ID: 15826603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of the early increase in intestinal permeability in critically ill patients.
    Ammori BJ
    Eur J Surg; 2002; 168(11):660-1; author reply 662. PubMed ID: 12699109
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis.
    Ammori BJ; Becker KL; Kite P; Snider RH; Nylén ES; White JC; Barclay GR; Larvin M; McMahon MJ
    Pancreas; 2003 Oct; 27(3):239-43. PubMed ID: 14508129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of abdominal sepsis on acute pancreatitis in rats: a study on mortality, permeability, arterial pressure, and intestinal blood flow.
    Andersson R; Wang X; Ihse I
    Pancreas; 1995 Nov; 11(4):365-73. PubMed ID: 8532653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal permeability and systemic endotoxemia in patients with acute pancreatitis.
    Schietroma M; Pessia B; Carlei F; Mariani P; Sista F; Amicucci G
    Ann Ital Chir; 2016; 87():138-44. PubMed ID: 27179282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional Aspects of Acute Pancreatitis.
    Roberts KM; Nahikian-Nelms M; Ukleja A; Lara LF
    Gastroenterol Clin North Am; 2018 Mar; 47(1):77-94. PubMed ID: 29413020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of intestinal permeability in relation to the inflammatory response and plasma endocab IgM levels in patients with acute pancreatitis.
    Penalva JC; Martínez J; Laveda R; Esteban A; Muñoz C; Sáez J; Such J; Navarro S; Feu F; Sánchez-Payá J; Pérez-Mateo M
    J Clin Gastroenterol; 2004 Jul; 38(6):512-7. PubMed ID: 15220687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut permeability and disease severity in acute pancreatitis.
    Tran DD
    Gastroenterology; 1993 Sep; 105(3):956-7. PubMed ID: 8359669
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective effects of vascular endothelial growth factor on intestinal epithelial apoptosis and bacterial translocation in experimental severe acute pancreatitis.
    Nakajima T; Ueda T; Takeyama Y; Yasuda T; Shinzeki M; Sawa H; Kuroda Y
    Pancreas; 2007 May; 34(4):410-6. PubMed ID: 17446839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The loss of αSNAP downregulates the expression of occludin in the intestinal epithelial cell of acute pancreatitis model.
    Chen D; Li L; Yan J; Yang X; You Y; Zhou Y; Ling X
    Pancreatology; 2014; 14(5):347-55. PubMed ID: 25278303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of resveratrol on the intestinal mucosal barrier in rats with severe acute pancreatitis.
    Jha RK; Yong MQ; Chen SH
    Med Sci Monit; 2008 Jan; 14(1):BR14-19. PubMed ID: 18160933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.